PTSDgene database

Study Report

Study Information
Basic Info
Reference
Citation Badour, C. L., et al. (2015). "Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans." J Anxiety Disord 36: 78-83.
Phenotype PTSD diagnosis
Trauma Combat
Study Design Case-control
Study Type Candidate gene association study
Sample Size 298 cases, 159 controls
SNP/Marker Size 1 SNP
Predominant Ethnicity Caucasian, Black
Population 315 White, 111 African American
Gender 82.3% males, 17.7% females
Age Case: mean age= 44.52 years, SD=14.75, Control: mean age= 43.95 years, SD=14.78

Detail Info

Genetic result reported by this study
Normal genetic result reported by this study (count: 1)
Marker Phenotype Related Gene Statistical Values Author Comments Marker's Category
rs1799923 PTSD diagnosis CCK B=0.77, OR= 2.17; 95% CI=[1.37-3.43], P-value< 0.01, controlling for combat exposure and recruitment site: B=0.68, OR = 1.97, P-value= .006, 95% CI: [1.21-3.19], among the subsample of white participants: B=0.88, OR= 2.50, P-value= 0.002, 95% CI: [1.42-4.40]. Specifically, relative to individuals with the CC genotype, ...... Specifically, relative to individuals with the CC genotype, those with the homozygous or heterozygous T allele were estimated to be 2.17 times more likely to have PTSD. This model remained significant when controlling for combat exposure and recruitment site. Among the subsample of White participants, those with the homozygous or heterozygous T allele were 2.50 times more likely to meet criteria for a PTSD diagnosis. More... Significant